Immune inhibitory proteins and their pathogenic and therapeutic implications in autoimmunity and autoimmune hepatitis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune inhibitory proteins and their pathogenic and therapeutic implications in autoimmunity and autoimmune hepatitis
Authors
Keywords
-
Journal
AUTOIMMUNITY
Volume -, Issue -, Pages 1-17
Publisher
Informa UK Limited
Online
2019-07-12
DOI
10.1080/08916934.2019.1641200
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Liver damage related to immune checkpoint inhibitors
- (2019) Naoshi Nishida et al. Hepatology International
- Hepatotoxicity induced by immune checkpoint inhibitors: a comprehensive review including current and alternative management strategies
- (2019) Joseph J. Jennings et al. Expert Opinion on Drug Metabolism & Toxicology
- Autoimmune phenomena and disease in cancer patients treated with immune checkpoint inhibitors
- (2018) Milena Tocut et al. AUTOIMMUNITY REVIEWS
- The structure, expression, and multifaceted role of immune-checkpoint protein VISTA as a critical regulator of anti-tumor immunity, autoimmunity, and inflammation
- (2018) Wenwen Xu et al. Cellular & Molecular Immunology
- Clinicopathological value of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) expression in synovium of patients with rheumatoid arthritis
- (2018) Kotaro Matsuda et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Under-Evaluated or Unassessed Pathogenic Pathways in Autoimmune Hepatitis and Implications for Future Management
- (2018) Albert J. Czaja DIGESTIVE DISEASES AND SCIENCES
- Epigenetic changes and their implications in autoimmune hepatitis
- (2018) Albert J. Czaja EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4–insufficient subjects
- (2018) Charlotte Schwab et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors
- (2018) Eleonora De Martin et al. JOURNAL OF HEPATOLOGY
- Dendritic Cell PD-L1 Limits Autoimmunity and Follicular T Cell Differentiation and Function
- (2018) Peter T. Sage et al. JOURNAL OF IMMUNOLOGY
- Hepatotoxicity of immune checkpoint inhibitors: An evolving picture of risk associated with a vital class of immunotherapy agents
- (2018) Daniel L. Suzman et al. LIVER INTERNATIONAL
- Prognostic significance of circulating soluble programmed death ligand-1 in patients with solid tumors
- (2018) Wei Wei et al. MEDICINE
- Hepatotoxicity of immune checkpoint inhibitors: a histology study of seven cases in comparison with autoimmune hepatitis and idiosyncratic drug-induced liver injury
- (2018) Yoh Zen et al. MODERN PATHOLOGY
- Delayed Autoimmune Toxicity Occurring Several Months After Cessation of Anti‐PD‐1 Therapy
- (2018) Sagun Parakh et al. ONCOLOGIST
- Diagnosis and Management of Hepatitis in Patients on Checkpoint Blockade
- (2018) Kerry Reynolds et al. ONCOLOGIST
- Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression
- (2018) Yanxia Guo et al. PLoS One
- Prior to Peripheral Tolerance, Newly Generated CD4 T Cells Maintain Dangerous Autoimmune Potential: Fas- and Perforin-Independent Autoimmunity Controlled by Programmed Death-1
- (2018) Kristofor K. Ellestad et al. Frontiers in Immunology
- Autoimmune hepatitis
- (2018) Giorgina Mieli-Vergani et al. Nature Reviews Disease Primers
- PD-1 Inhibitor Immune-Related Adverse Events in Patients with Preexisting Endocrine Autoimmunity
- (2018) Halis Kaan Akturk et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- Immune Checkpoint Inhibitor-Associated Colits and Hepatitis
- (2018) Haritha G. Reddy et al. Clinical and Translational Gastroenterology
- The Nobel Prize for Medicine awarded for cancer therapy by inhibition of negative immune regulation
- (2018) Peter Hokland et al. BRITISH JOURNAL OF HAEMATOLOGY
- Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study
- (2018) Maria Pia Pistillo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines
- (2018) Nadine van Montfoort et al. CELL
- NKG2A, a New Kid on the Immune Checkpoint Block
- (2018) John B. Haanen et al. CELL
- Immune-related adverse events of immune checkpoint inhibitors: a brief review
- (2018) G. Myers Current Oncology
- Next Steps for Immune Checkpoints in Hepatocellular Carcinoma
- (2018) Patricia M. Santos et al. GASTROENTEROLOGY
- Antibodies to watch in 2019
- (2018) Hélène Kaplon et al. mAbs
- Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine
- (2018) Jake R. Conway et al. Genome Medicine
- Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
- (2018) Samantha L. Bucktrout et al. Genome Medicine
- The Balancing Act between Cancer Immunity and Autoimmunity in Response to Immunotherapy
- (2018) Arabella Young et al. Cancer Immunology Research
- Inhibitory Receptors and Pathways of Lymphocytes: The Role of PD-1 in Treg Development and Their Involvement in Autoimmunity Onset and Cancer Progression
- (2018) Elena Gianchecchi et al. Frontiers in Immunology
- CTLA-4 and PD-1 Control of T-Cell Motility and Migration: Implications for Tumor Immunotherapy
- (2018) Monika C. Brunner-Weinzierl et al. Frontiers in Immunology
- Evolving paradigm of treatment for autoimmune hepatitis
- (2017) Albert J. Czaja Expert Review of Clinical Immunology
- EFIS Lecture: Understanding the CTLA-4 checkpoint in the maintenance of immune homeostasis
- (2017) Lucy S.K. Walker IMMUNOLOGY LETTERS
- Checkpoint-based immunotherapy for autoimmune diseases – Opportunities and challenges
- (2017) Xiao-Song He et al. JOURNAL OF AUTOIMMUNITY
- PD-L1
- (2017) Anthousa Kythreotou et al. JOURNAL OF CLINICAL PATHOLOGY
- PD-L1 Prevents the Development of Autoimmune Heart Disease in Graft-versus-Host Disease
- (2017) Kathryn W. Juchem et al. JOURNAL OF IMMUNOLOGY
- Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers
- (2017) Y Liu et al. ONCOGENE
- Soluble cytotoxic T-lymphocyte antigen 4: a favorable predictor in malignant tumors after therapy
- (2017) Qiqi Liu et al. OncoTargets and Therapy
- T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV-1 patients
- (2017) Sebastian Bolduan et al. Journal of the International AIDS Society
- PD-1/PD-L and autoimmunity: A growing relationship
- (2016) Mohammad Reza Zamani et al. CELLULAR IMMUNOLOGY
- Reversing T-cell Dysfunction and Exhaustion in Cancer
- (2016) H. M. Zarour CLINICAL CANCER RESEARCH
- T cell exhaustion and immune-mediated disease—the potential for therapeutic exhaustion
- (2016) Eoin F McKinney et al. CURRENT OPINION IN IMMUNOLOGY
- Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family
- (2016) Frank A. Schildberg et al. IMMUNITY
- T-cell exhaustion: understanding the interface of chronic viral and autoinflammatory diseases
- (2016) Eoin F McKinney et al. IMMUNOLOGY AND CELL BIOLOGY
- The role of neoantigens in response to immune checkpoint blockade
- (2016) Nadeem Riaz et al. INTERNATIONAL IMMUNOLOGY
- B-Cell Activating Factor Belonging to the Tumor Necrosis Factor Family and Interferon-γ-Inducible Protein-10 in Autoimmune Hepatitis
- (2016) Hiroki Nishikawa et al. MEDICINE
- Immune checkpoints and rheumatic diseases: what can cancer immunotherapy teach us?
- (2016) Michiel van der Vlist et al. Nature Reviews Rheumatology
- Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
- (2016) Vassiliki A. Boussiotis NEW ENGLAND JOURNAL OF MEDICINE
- Soluble programmed death-1 levels are associated with disease activity and treatment response in patients with autoimmune hepatitis
- (2016) Kristian Aarslev et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Programmed Death-1 Culls Peripheral Accumulation of High-Affinity Autoreactive CD4 T Cells to Protect against Autoimmunity
- (2016) Tony T. Jiang et al. Cell Reports
- The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation
- (2016) Kankana Bardhan et al. Frontiers in Immunology
- Rituximab for the Treatment of Patients with Autoimmune Hepatitis Who are Refractory or Intolerant to Standard Therapy
- (2016) Kelly W Burak et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Ipilimumab-associated Hepatitis
- (2015) Melanie Johncilla et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Epigenetics changes associated to environmental triggers in autoimmunity
- (2015) Carlos A. Cañas et al. AUTOIMMUNITY
- Transitioning from Idiopathic to Explainable Autoimmune Hepatitis
- (2015) Albert J. Czaja DIGESTIVE DISEASES AND SCIENCES
- HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1
- (2015) N M F van Gerven et al. GENES AND IMMUNITY
- CD4 + T Cell Tolerance to Tissue-Restricted Self Antigens Is Mediated by Antigen-Specific Regulatory T Cells Rather Than Deletion
- (2015) Francois P. Legoux et al. IMMUNITY
- Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients
- (2015) Mark R. Rigby et al. JOURNAL OF CLINICAL INVESTIGATION
- Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial
- (2015) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- EASL Clinical Practice Guidelines: Autoimmune hepatitis
- (2015) JOURNAL OF HEPATOLOGY
- T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection
- (2015) Eoin F. McKinney et al. NATURE
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of soluble programmed death-1 (sPD-1) and sPD-ligand 1 in patients with cystic echinococcosis
- (2015) YANHUA LI et al. Experimental and Therapeutic Medicine
- PD-1 expression on dendritic cells suppresses CD8+ T cell function and antitumor immunity
- (2015) Tong Seng Lim et al. OncoImmunology
- High CTLA-4 Expression on Th17 Cells Results in Increased Sensitivity to CTLA-4 Coinhibition and Resistance to Belatacept
- (2014) S. M. Krummey et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Current and prospective pharmacotherapy for autoimmune hepatitis
- (2014) Albert J Czaja EXPERT OPINION ON PHARMACOTHERAPY
- Genome-Wide Association Study Identifies Variants Associated With Autoimmune Hepatitis Type 1
- (2014) Ynto S. de Boer et al. GASTROENTEROLOGY
- Interference with PD-L1/PD-1 co-stimulation during antigen presentation enhances the multifunctionality of antigen-specific T cells
- (2014) J J Pen et al. GENE THERAPY
- Epigenetics in liver disease
- (2014) Derek A. Mann HEPATOLOGY
- Multicenter validation study of anti-programmed cell death-1 antibody as a serological marker for type 1 autoimmune hepatitis
- (2014) Yasuhiro Miyake et al. HEPATOLOGY RESEARCH
- Molecular and Transcriptional Basis of CD4+ T Cell Dysfunction during Chronic Infection
- (2014) Alison Crawford et al. IMMUNITY
- Exploiting CTLA-4, PD-1 and PD-L1 to reactivate the host immune response against cancer
- (2013) S A Quezada et al. BRITISH JOURNAL OF CANCER
- Ipilimumab associated hepatitis: imaging and clinicopathologic findings
- (2013) Kyung Won Kim et al. INVESTIGATIONAL NEW DRUGS
- Anti-programmed cell death-1 antibody as a new serological marker for type 1 autoimmune hepatitis
- (2013) Kazuyuki Matsumoto et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Negative role of inducible PD-1 on survival of activated dendritic cells
- (2013) S. J. Park et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression
- (2013) Tomoyuki Yamaguchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Summary of the US FDA Approval of Belatacept
- (2012) P. Archdeacon et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Deleterious Effect of CTLA4-Ig on a Treg-Dependent Transplant Model
- (2012) L. V. Riella et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
- (2012) Suzanne L Topalian et al. CURRENT OPINION IN IMMUNOLOGY
- Pathologic Changes in Ipilimumab-Related Hepatitis in Patients with Metastatic Melanoma
- (2012) David E. Kleiner et al. DIGESTIVE DISEASES AND SCIENCES
- PD-1 is a novel regulator of human B-cell activation
- (2012) Marie-Laure Thibult et al. INTERNATIONAL IMMUNOLOGY
- Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis
- (2012) Janine Ehser et al. JOURNAL OF AUTOIMMUNITY
- Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis
- (2012) Christina Weiler-Normann et al. JOURNAL OF HEPATOLOGY
- Cutting Edge: Cell-Extrinsic Immune Regulation by CTLA-4 Expressed on Conventional T Cells
- (2012) C. J. Wang et al. JOURNAL OF IMMUNOLOGY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo
- (2012) J. Gotot et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Successful rituximab therapy in refractory autoimmune hepatitis and Evans syndrome
- (2012) Elizabeth J Carey et al. REVISTA MEDICA DE CHILE
- Selective CD28 Blockade Attenuates Acute and Chronic Rejection of Murine Cardiac Allografts in a CTLA-4-Dependent Manner
- (2011) T. Zhang et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The epigenetics of autoimmunity
- (2011) Francesca Meda et al. Cellular & Molecular Immunology
- Promising Pharmacological, Molecular and Cellular Treatments of Autoimmune Hepatitis
- (2011) Albert J. Czaja CURRENT PHARMACEUTICAL DESIGN
- Development of a sandwich ELISA for evaluating soluble PD-L1 (CD274) in human sera of different ages as well as supernatants of PD-L1+ cell lines
- (2011) Yongjing Chen et al. CYTOKINE
- British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis
- (2011) D. Gleeson et al. GUT
- Soluble B7-H1: Differences in production between dendritic cells and T cells
- (2011) Xavier Frigola et al. IMMUNOLOGY LETTERS
- Programmed death-1 is required for systemic self-tolerance in newly generated T cells during the establishment of immune homeostasis
- (2011) G. Thangavelu et al. JOURNAL OF AUTOIMMUNITY
- Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model
- (2011) Edith Hintermann et al. JOURNAL OF AUTOIMMUNITY
- Enhancement of Vaccine-induced Primary and Memory CD8+ T-cell Responses by Soluble PD-1
- (2011) Mi-Young Song et al. JOURNAL OF IMMUNOTHERAPY
- PD-1 Blockade by CT-011, Anti-PD-1 Antibody, Enhances Ex Vivo T-cell Responses to Autologous Dendritic Cell/Myeloma Fusion Vaccine
- (2011) Jacalyn Rosenblatt et al. JOURNAL OF IMMUNOTHERAPY
- T cell exhaustion
- (2011) E John Wherry NATURE IMMUNOLOGY
- Quantitative impact of thymic selection on Foxp3+ and Foxp3- subsets of self-peptide/MHC class II-specific CD4+ T cells
- (2011) J. J. Moon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4
- (2011) O. S. Qureshi et al. SCIENCE
- The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: Results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial
- (2010) J. T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Carriage of a tumor necrosis factor polymorphism amplifies the cytotoxic T-lymphocyte antigen 4 attributed risk of primary biliary cirrhosis: Evidence for a gene-gene interaction
- (2010) Brian D. Juran et al. HEPATOLOGY
- Diagnosis and management of autoimmune hepatitis
- (2010) Michael P. Manns et al. HEPATOLOGY
- The PD-1 pathway in tolerance and autoimmunity
- (2010) Loise M. Francisco et al. IMMUNOLOGICAL REVIEWS
- T-cell exhaustion: characteristics, causes and conversion
- (2010) John S. Yi et al. IMMUNOLOGY
- Five-Year Safety and Efficacy of Belatacept in Renal Transplantation
- (2010) F. Vincenti et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- CTLA-4 (CD152) inhibits T cell function by activating the ubiquitin ligase Itch
- (2010) Holger Hoff et al. MOLECULAR IMMUNOLOGY
- Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity
- (2010) N. Jain et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immune Checkpoint Proteins: A New Therapeutic Paradigm for Cancer—Preclinical Background: CTLA-4 and PD-1 Blockade
- (2010) Jeffrey Weber SEMINARS IN ONCOLOGY
- A more selective costimulatory blockade of the CD28-B7 pathway
- (2010) Nicolas Poirier et al. TRANSPLANT INTERNATIONAL
- ORIGINAL ARTICLE: PD-1 but not CTLA-4 Blockage Abrogates the Protective Effect of Regulatory T Cells in a Pregnancy Murine Model
- (2009) Paul Ojiambo Wafula et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Programmed Death-1 Antibody Blocks Therapeutic Effects of T-Regulatory Cells in Cockroach Antigen-Induced Allergic Asthma
- (2009) Halvor S. McGee et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice
- (2009) Paula Kolar et al. ARTHRITIS AND RHEUMATISM
- Abatacept, a Novel CD80/86-CD28 T Cell Co-stimulation Modulator, in the Treatment of Rheumatoid Arthritis
- (2009) Riku Korhonen et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- PD-1 on dendritic cells impedes innate immunity against bacterial infection
- (2009) S. Yao et al. BLOOD
- Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms
- (2009) Jacek Daroszewski et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels
- (2009) Ulrike Lorenz IMMUNOLOGICAL REVIEWS
- The clinical utility of inhibiting CD28-mediated costimulation
- (2009) Peter S. Linsley et al. IMMUNOLOGICAL REVIEWS
- CD28 and CTLA-4 coreceptor expression and signal transduction
- (2009) Christopher E. Rudd et al. IMMUNOLOGICAL REVIEWS
- A functional soluble form of CTLA-4 is present in the serum of celiac patients and correlates with mucosal injury
- (2009) R. Simone et al. INTERNATIONAL IMMUNOLOGY
- PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+CD25Hi regulatory T cells
- (2009) Wenshi Wang et al. INTERNATIONAL IMMUNOLOGY
- Rituximab-responsive Cryoglobulinemic Glomerulonephritis in a Patient With Autoimmune Hepatitis
- (2009) Joshua T. Evans et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
- (2009) Loise M. Francisco et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
- (2009) Karl S. Peggs et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR–induced stop signal
- (2009) Brian T Fife et al. NATURE IMMUNOLOGY
- Intraclonal competition limits the fate determination of regulatory T cells in the thymus
- (2009) Jhoanne L Bautista et al. NATURE IMMUNOLOGY
- CD152 (CTLA-4) Determines CD4 T Cell Migration In Vitro and In Vivo
- (2009) Karin Knieke et al. PLoS One
- TGF-β and IL-10 Production by HIV-Specific CD8+ T Cells Is Regulated by CTLA-4 Signaling on CD4+ T Cells
- (2009) Mohamed Elrefaei et al. PLoS One
- B7-H1 (PD-L1) on T cells is required for T-cell-mediated conditioning of dendritic cell maturation
- (2009) Oezcan Talay et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Vital Role for Interleukin-21 in the Control of a Chronic Viral Infection
- (2009) J. S. Yi et al. SCIENCE
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Genetic Factors Affecting the Occurrence, Clinical Phenotype, and Outcome of Autoimmune Hepatitis
- (2008) Albert J. Czaja Clinical Gastroenterology and Hepatology
- Primary Biliary Cirrhosis Is Associated With a Genetic Variant in the 3′ Flanking Region of the CTLA4 Gene
- (2008) Brian D. Juran et al. GASTROENTEROLOGY
- Fatal Autoimmune Hepatitis Induced by Concurrent Loss of Naturally Arising Regulatory T Cells and PD-1-Mediated Signaling
- (2008) Masahiro Kido et al. GASTROENTEROLOGY
- Association of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with type 1 autoimmune hepatitis in Japanese
- (2008) Takeji Umemura et al. HEPATOLOGY RESEARCH
- Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future
- (2008) Marc Daëron et al. IMMUNOLOGICAL REVIEWS
- Soluble PD-1 rescues the proliferative response of simian immunodeficiency virus-specific CD4 and CD8 T cells during chronic infection
- (2008) Nattawat Onlamoon et al. IMMUNOLOGY
- Enhancing SIV-specific immunity in vivo by PD-1 blockade
- (2008) Vijayakumar Velu et al. NATURE
- Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
- (2008) Shawn D Blackburn et al. NATURE IMMUNOLOGY
- Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells
- (2008) L. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection
- (2008) D. G. Brooks et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CTLA-4 Control over Foxp3+ Regulatory T Cell Function
- (2008) K. Wing et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search